WO1997013858A3 - Baboon mage-3 homologs, dna encoding the homologs, and a process for their use - Google Patents
Baboon mage-3 homologs, dna encoding the homologs, and a process for their use Download PDFInfo
- Publication number
- WO1997013858A3 WO1997013858A3 PCT/US1996/016319 US9616319W WO9713858A3 WO 1997013858 A3 WO1997013858 A3 WO 1997013858A3 US 9616319 W US9616319 W US 9616319W WO 9713858 A3 WO9713858 A3 WO 9713858A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- homologs
- mage
- baboon
- dna encoding
- tumors
- Prior art date
Links
- 241001504519 Papio ursinus Species 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU74401/96A AU7440196A (en) | 1995-10-12 | 1996-10-10 | Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US511795P | 1995-10-12 | 1995-10-12 | |
US60/005,117 | 1995-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997013858A2 WO1997013858A2 (en) | 1997-04-17 |
WO1997013858A3 true WO1997013858A3 (en) | 1997-06-05 |
Family
ID=21714271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/016319 WO1997013858A2 (en) | 1995-10-12 | 1996-10-10 | Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7440196A (en) |
WO (1) | WO1997013858A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686068A (en) * | 1994-03-24 | 1997-11-11 | Ludwig Institute For Cancer Research | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof |
US6475727B1 (en) | 1997-04-11 | 2002-11-05 | Micromet Gesellschaft Fur Biomedizinische Forschung Mbh | Primers and methods for the detection of disseminated tumor cells |
US5965535A (en) | 1997-09-12 | 1999-10-12 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
ES2255248T3 (en) | 1998-02-05 | 2006-06-16 | Glaxosmithkline Biologicals S.A. | DERIVATIVES OF ANTIGENS ASSOCIATED TO TUMOR OF THE MAGE FAMILY, AND SEQUENCES OF NUCLEIC ACIDS THAT CODIFY THEM, USED FOR THE PREPARATION OF FUSION PROTEINS AND COMPOSITIONS FOR VACCINES. |
CA2393339A1 (en) * | 1999-12-10 | 2001-06-14 | Epimmune Inc. | Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions |
US7049413B2 (en) | 2001-05-18 | 2006-05-23 | Ludwig Institute For Cancer Research | MAGE-A3 peptides presented by HLA class II molecules |
WO2010143010A1 (en) * | 2009-06-09 | 2010-12-16 | Vaxon Biotech | Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023031A1 (en) * | 1993-03-26 | 1994-10-13 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
-
1996
- 1996-10-10 AU AU74401/96A patent/AU7440196A/en not_active Abandoned
- 1996-10-10 WO PCT/US1996/016319 patent/WO1997013858A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023031A1 (en) * | 1993-03-26 | 1994-10-13 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
Non-Patent Citations (3)
Title |
---|
B. GAUGLER ET AL.: "HUMAN GENE MAGE-3 CODES FOR AN ANTIGEN RECOGNIZED ON A MELANOMA BY AUTOLOGOUS CYTOLYTIC T LYMPHOCYTES", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 179, no. 3, 1 March 1994 (1994-03-01), pages 921 - 930, XP000614538 * |
O. DE BACKER ET AL.: "STRUCTURE, CHROMOSOME LOCATION, AND EXPRESSION PATTERN OF THREE MOUSE GENES HOMOLOGOUS TO THE HUMAN MAGE GENES", GENOMICS, vol. 28, no. 1, 1 July 1995 (1995-07-01), pages 74 - 93, XP000670311 * |
PLAEN DE E ET AL: "STRUCTURE, CHROMOSOMAL LOCALIZATION, AND EXPRESSION OF 12 GENES OF THE MAGE FAMILY", IMMUNOGENETICS, vol. 40, no. 5, 1994, pages 360 - 369, XP000614537 * |
Also Published As
Publication number | Publication date |
---|---|
AU7440196A (en) | 1997-04-30 |
WO1997013858A2 (en) | 1997-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4903101A (en) | Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof | |
AU1218295A (en) | Adjuvant for antigens, process for producing the same and its use | |
AU4293693A (en) | Catalyzed cationic lacquer binder, process for producing the same and its use | |
AU2186095A (en) | Biometric, personal authentication system | |
AU5047800A (en) | Breast, gastric and prostate cancer associated antigens and uses therefor | |
CY2440B1 (en) | Process improvement in the synthesis of N-A3-(3-cyanopyrazolo A1,5-aUpyrimidin-7-yl)phenylU-N-ethyl-acetamide. | |
ZA9711090B (en) | Process for the preparation of hydrocarbons. | |
ZA966441B (en) | Hydrocarbon alkylation process. | |
ZA964711B (en) | Novel compounds, the preparation and use thereof. | |
AU7198291A (en) | Human monoclonal antibodies against rabies viruses, the production and the use thereof | |
EP0660700A4 (en) | Method for permanently shaping keratinous materials. | |
ZA975588B (en) | Isolated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof. | |
WO1997013858A3 (en) | Baboon mage-3 homologs, dna encoding the homologs, and a process for their use | |
ZA9610278B (en) | Pyridylcarbamates, processes and intermediates for their preparation, and their use. | |
ZA974084B (en) | Novel α-glucuronidases, production hereof and their uses. | |
EP0622369A3 (en) | 2-Amino-4-quinoline-dihydropyridine, process for preparation and use thereof. | |
ZA966474B (en) | Method for preparing mineral pigments, the thus obtained mineral pigments and installation for implementing such method. | |
EP0613634A3 (en) | Process for producing sticks, especially cosmetic sticks. | |
AU6609298A (en) | Dual tube system, method and tools for the production thereof | |
AU5997096A (en) | Cocoa flavour precursor peptides, dna encoding them, process es for producing the peptides, and their use for generating cocoa flavour | |
HUP9700747A1 (en) | Novel retinoids, pharmaceutical compns. contg. them and process for preparing the said compds. | |
AU6820198A (en) | Cyclodextrin modifications with molecular channels, method for the production and use thereof | |
EP0614971A3 (en) | Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin using the same. | |
EP0675171A3 (en) | Reactive dyes, process for their preparation and the use thereof. | |
EP0757098A3 (en) | Heat resistant maltose phosphorylase, process for preparation thereof, bacteria used for preparation thereof, and methods for using the enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97515226 Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |